The team from Charity Navigator*, the nation’s largest independent charity evaluator and leading donor advocate, listed the Bladder Cancer Advocacy Network as one of America’s 10 Best Medical Research Organizations! We could not have done it with out the support of our researchers and the entire bladder cancer community that helps
Bladder Cancer News
Congratulations on PCORI 2018 CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer Award
Congratulations to the University of Washington’s Dr. John Gore and Dr. Angela Smith from the University of North Carolina, along with a team of researchers who have been awarded funding for a pragmatic (conducted in a real-world clinical practice setting) clinical study designed to evaluate patient-centered outcomes. Support for this
BCAN Announces 2018 Bladder Cancer Research Innovation Awardee
The aim of the Bladder Cancer Research Innovation Award is to support exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. BCAN is pleased to announce The JPB Foundation 2018 Bladder Cancer Research Innovation Award was granted to Michael M. Shen, PhD for
ANNOUNCING AWARDEES OF THE 2018 YOUNG INVESTIGATOR AWARDS
The Bladder Cancer Advocacy Network Announces Awardees of our 2018 Young Investigator Awards Today, the Bladder Cancer Advocacy Network (BCAN) announced the names of the recipients of the 2018 Young Investigator Awards These Awards support the development of outstanding early career research scientists and clinical cancer research investigators who have demonstrated
BCAN THANKS US SENATE FOR DESIGNATING MAY AS “BLADDER CANCER AWARENESS MONTH”
Bethesda, Maryland – The Bladder Cancer Advocacy Network (BCAN) would like to thank Senators Bob Menendez (D-NJ) and Johnny Isakson (R-GA), as well as every member of the US Senate, for their unanimous support for a resolution officially declaring May 2018 as “Bladder Cancer Awareness Month.” With the passage of
Photocure Announces FDA Approval of New Drug Application for Blue Light Cystoscopy with Cysview®
February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®. This supplemental new drug application (sNDA) will include Flexible Cystoscopes, which are used in the ongoing surveillance of bladder cancer patients bladder cancer. It is the only combination of drug
Checkpoint Inhibitors Show Promise in Bladder Cancer
With no new bladder cancer treatment approvals in 30 years, 2016 proved to be a breakthrough year in bladder cancer research. It kicked off this year’s rapid expansion of several immunotherapies now available to patients with metastatic bladder cancer, revolutionizing the treatment of this disease. “Before, we could offer chemotherapy, which
HealthWell Foundation® now offers some financial assistance to Medicare patients with bladder cancer.
Bladder and Urothelial Cancers Fund Opens at HealthWell Foundation The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has opened a new fund to provide copayment and premium assistance to eligible Medicare patients living with bladder or urothelial cancer. Through the fund, HealthWell will
Bladder Cancer: A Patient-Friendly Guide to Understanding Your Diagnosis and Treatment Options is now available
Following a bladder cancer diagnosis in 2007, David Pulver went for a second opinion to Dr. Mark Schoenberg, a renowned urologist and expert in the field of urology. Together and alongside other doctors and patients, they wrote a patient-friendly book for those diagnosed with this disease. Bladder Cancer: A Patient-Friendly Guide to Understanding Your